期刊文献+

米非司酮固体脂质纳米粒冷冻干燥性能的研究 被引量:7

Studies on the Characteristics of Freeze-Dried Solid Lipid Nanoparticles Loading Mifepristone
在线阅读 下载PDF
导出
摘要 目的 :考察几种冻干保护剂对载药SLN冻干过程中的保护作用 ,并筛选出最佳的配方。方法 :通过测定载药SLN冻干前后的载药量和粒度变化 ,来评价保护效果和优选配方 ,并通过TEM和AFM进行了形态学观察。结果 :浓度为 2 0 %的海藻糖可以对载药SLN起到较佳的保护效果 ,试样的包封率高达 79% (冻干前88% ) ,粒径 2 4 7nm(冻干前 10 9nm) ,并且多分散系数 0 .12 1大大低于冻干前的 (0 .2 4 6 ) ,为SLN载体系统的建立稳定剂型和长期保存开辟了前景。结论 :选用合适浓度的冻干保护剂在合理的冻干条件下可以获得令人满意的载药冻干SLN试样。 AIM:Several cryoprotectants were employed to study the protective effect on the drug loading solid lipid nanoparticles(SLN) in order to select the optimum formulation.METHOD:The protective effect was evaluated by encapsulation efficiency and mean particle size of samples before and after freeze-drying process,and the morphologic study was performed by TEM and AFM.RESULT:The excellent protective effect could be obtained when trehalose was added to the sample with the concentration of 20%.Excellent sample was with the EE% of 79%(versus 88% of fresh one),mean particle size of 247 nm(versus 109 nm of fresh one),and a much lowered polydispersity index of 0.121(versus 0.246).CONCLUSION:The satisfactory result could be achieved with suitable type of cryoprotectant with appropriate concentration and proper freeze-drying condition.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2004年第5期413-416,共4页 Journal of China Pharmaceutical University
基金 国家自然科学基金资助项目 (No .5 0 2 710 2 9)~~
关键词 SLN 载药量 固体脂质纳米粒 米非司酮 冻干保护剂 保护效果 保护作用 分散系数 粒径 配方 Solid lipid nanoparticles Cryoprotectant Encapsulation efficiency
  • 相关文献

参考文献12

  • 1Müller RH,Karsten M,Sven G.Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state or the art[J].Eur J Pharm Biopham,2000,50(5):161-177.
  • 2Müller RH,Mehnert W,Lucks JS,et al.Solid lipid nanoparticles(SLN)-an alternative colloidal carrier system for controlled drug delivery[J].Eur J Pharm Biopharm,1995,41(2):62-69.
  • 3Westesen K.Particles with modified physicochemical properties,their preparation and uses.U.S.Patent:6197349,2001-02-07.
  • 4Hou DZ,Xie CS,Zhu CH,et al.The production and charachteristics of solid lipid nanoparticles[J].Biomaterials,2003,24(5):1781-1785.
  • 5Hou DZ,Xie CS.Combined surfactants to produce favorable physical stable solid lipid nanoparticles(SLNs) systems[J].中国药科大学学报(J China Pharm Univ),印刷中.
  • 6侯冬枝,谢长生,朱长虹.固体脂质纳米粒的制备和载体结构的研究进展及其应用[J].中国医院药学杂志,2004,24(1):43-45. 被引量:13
  • 7李飞飞,陈玉霞,唐建华.小剂量米非司酮紧急避孕150例临床观察[J].第一军医大学学报,2002,22(5):466-466. 被引量:2
  • 8Allisons D,Theodore W R.Effects of drying method and additives on structure and function of actin[J].Arch Biochem Biophy,1998,64(3):171-181.
  • 9刘占杰,华泽钊,李保国,陈儿同.降温速率对脂质体冻干品质量影响的实验研究[J].真空与低温,2000,6(4):217-220. 被引量:3
  • 10Christensen KL,Pedersen GP,Kristensen HG.Physical stability of redispersible dry emulsions containing amorphous sucrose[J].Eur J Pharm Biopharm,2002,53(2):147-153.

二级参考文献15

  • 1[1]Muhlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism[J]. Eur J Pharm Biopharrn, 1998, 45(3): 149.
  • 2[2]Kopecek I, Kopeckoya P, Minko T. HPMA copolymer bound anticancer drug mechanism of action on cellular and subcellular levels [J]. Prog Int Symp Cont rolled Rel Bioact Mater, 1999,26 ( 1 ): 24.
  • 3[3]Torchilin VP. Liposomes as targetable drug carriers[J]. Crit Rev Ther Drug Carrier Syst, 1985,2(2): 65.
  • 4[4]Trotta M, Pattarino F, Ignoni T. Stability of drug-carrier emul sions containing phosphatidylcholine mixtures[J]. Eur J Pharm Biopharm, 2002,53(4): 203.
  • 5[5]MμLler RH, Mehnert W, Lucks JS, et al. Solid lipid nanoparticles( SLN)-an alternative colloidal carrier system for controlleddrug delivery[J ]. Eur J Pharm Biopharm, 1995,41 (2): 62.
  • 6[6]Jahmke S. The theory of high pressure homogenization[ M]. in:Muller RH, Benita S, Emulsion and nanosuspensions for the for mulation of poorly soluble drugs. Medpharm Scientific Publish ers, stuttgart, B Bohm(Eds), 1998.177.
  • 7[7]Antonio JA, Runge S, Muller RH. Peptide-loaded solid lipid nanoparticles(SLN): influence of production parameters[J]. Int J Pharm, 1997, 149(6):255.
  • 8[8]Siekmann B, Westesen K. Investigation on solid lipid nanoparti cles prepared by precipitation in O/W emulsion[J]. Eur J Pharm Biopharm, 1996,43(2): 104.
  • 9[9]Gasco MS. Method for producing solid lipid nanospheres having a narrow size distribution[ P]. US Patent, 5250236, 1993-11-01.
  • 10[10]Muhlen A, Mehnert W. Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles [ J ]. Pharmazie, 1998,53(11): 552.

共引文献15

同被引文献52

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部